Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for TBX1
Z-value: 1.68
Motif logo
Transcription factors associated with TBX1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TBX1
|
ENSG00000184058.8 | T-box transcription factor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TBX1 | hg19_v2_chr22_+_19744226_19744226 | 0.36 | 3.3e-08 | Click! |
Activity profile of TBX1 motif
Sorted Z-values of TBX1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_+_37407212 | 28.40 |
ENST00000427117.1
ENST00000587130.1 ENST00000333987.7 ENST00000415168.1 ENST00000444991.1 |
ZNF568
|
zinc finger protein 568 |
| chr19_+_56915668 | 27.71 |
ENST00000333201.9
ENST00000391778.3 |
ZNF583
|
zinc finger protein 583 |
| chr22_-_27620603 | 23.00 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
| chr19_-_9731872 | 22.46 |
ENST00000424629.1
ENST00000326044.5 ENST00000354661.4 ENST00000435550.1 ENST00000444611.1 ENST00000421525.1 |
ZNF561
|
zinc finger protein 561 |
| chr1_+_89829610 | 20.14 |
ENST00000370456.4
ENST00000535065.1 |
GBP6
|
guanylate binding protein family, member 6 |
| chr4_-_120133661 | 19.51 |
ENST00000503243.1
ENST00000326780.3 |
RP11-455G16.1
|
Uncharacterized protein |
| chr3_-_57678772 | 18.94 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
| chr18_+_21693306 | 18.30 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
| chr11_-_64511789 | 17.25 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr11_-_115630900 | 17.16 |
ENST00000537070.1
ENST00000499809.1 ENST00000514294.2 ENST00000535683.1 |
LINC00900
|
long intergenic non-protein coding RNA 900 |
| chr13_+_114567131 | 17.01 |
ENST00000608651.1
|
GAS6-AS2
|
GAS6 antisense RNA 2 (head to head) |
| chr16_+_31271274 | 16.09 |
ENST00000287497.8
ENST00000544665.3 |
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit) |
| chr17_-_5138099 | 15.59 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
| chr15_-_42076229 | 15.17 |
ENST00000597767.1
|
AC073657.1
|
Uncharacterized protein |
| chr19_+_45973120 | 14.91 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr11_-_76155618 | 14.40 |
ENST00000530759.1
|
RP11-111M22.3
|
RP11-111M22.3 |
| chr20_+_30640004 | 14.39 |
ENST00000520553.1
ENST00000518730.1 ENST00000375852.2 |
HCK
|
hemopoietic cell kinase |
| chr14_+_75746781 | 14.31 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr1_-_15911510 | 13.58 |
ENST00000375826.3
|
AGMAT
|
agmatine ureohydrolase (agmatinase) |
| chr12_-_53594227 | 13.57 |
ENST00000550743.2
|
ITGB7
|
integrin, beta 7 |
| chr11_-_76155700 | 13.27 |
ENST00000572035.1
|
RP11-111M22.3
|
RP11-111M22.3 |
| chr22_-_17702729 | 13.11 |
ENST00000449907.2
ENST00000441548.1 ENST00000399839.1 |
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
| chr19_-_51875894 | 12.93 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
| chr21_-_46340884 | 12.70 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr6_-_84937314 | 12.60 |
ENST00000257766.4
ENST00000403245.3 |
KIAA1009
|
KIAA1009 |
| chr4_+_128554081 | 12.43 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
| chr12_-_10022735 | 12.29 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
| chr18_+_74240610 | 11.72 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
| chr21_-_46340770 | 11.67 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr8_+_1993173 | 11.32 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
| chr6_-_74161977 | 11.11 |
ENST00000370318.1
ENST00000370315.3 |
MB21D1
|
Mab-21 domain containing 1 |
| chr1_+_28199047 | 11.05 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
| chr18_+_71815743 | 10.92 |
ENST00000169551.6
ENST00000580087.1 |
TIMM21
|
translocase of inner mitochondrial membrane 21 homolog (yeast) |
| chr7_+_99816859 | 10.85 |
ENST00000317271.2
|
PVRIG
|
poliovirus receptor related immunoglobulin domain containing |
| chr12_+_32112340 | 10.81 |
ENST00000540924.1
ENST00000312561.4 |
KIAA1551
|
KIAA1551 |
| chr5_-_131132614 | 10.55 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
| chr12_-_8025499 | 10.36 |
ENST00000431042.2
|
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14 |
| chrX_-_103401649 | 10.13 |
ENST00000357421.4
|
SLC25A53
|
solute carrier family 25, member 53 |
| chr16_+_53468332 | 10.09 |
ENST00000262133.6
|
RBL2
|
retinoblastoma-like 2 (p130) |
| chr5_-_137514617 | 10.06 |
ENST00000254900.5
|
BRD8
|
bromodomain containing 8 |
| chr2_+_90248739 | 9.75 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
| chr8_+_12809093 | 9.73 |
ENST00000528753.2
|
KIAA1456
|
KIAA1456 |
| chr2_-_89310012 | 9.51 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chrX_+_128913906 | 9.51 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
| chr14_-_106054659 | 9.48 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr12_-_8025623 | 9.36 |
ENST00000542782.1
ENST00000396589.2 ENST00000535266.1 ENST00000542505.1 |
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14 |
| chr12_-_54691668 | 9.34 |
ENST00000553198.1
|
NFE2
|
nuclear factor, erythroid 2 |
| chr1_+_111773349 | 9.30 |
ENST00000533831.2
|
CHI3L2
|
chitinase 3-like 2 |
| chr19_-_39826639 | 9.25 |
ENST00000602185.1
ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG
|
glia maturation factor, gamma |
| chr16_-_30546141 | 9.12 |
ENST00000535210.1
ENST00000395094.3 |
ZNF747
|
zinc finger protein 747 |
| chr1_-_15735925 | 9.08 |
ENST00000427824.1
|
RP3-467K16.4
|
RP3-467K16.4 |
| chr14_-_106174960 | 8.86 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr16_+_2587998 | 8.80 |
ENST00000441549.3
ENST00000268673.7 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
| chr12_-_15104040 | 8.80 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr16_-_46865047 | 8.80 |
ENST00000394806.2
|
C16orf87
|
chromosome 16 open reading frame 87 |
| chr9_+_10613163 | 8.79 |
ENST00000429581.2
|
RP11-87N24.2
|
RP11-87N24.2 |
| chr2_-_196933536 | 8.76 |
ENST00000312428.6
ENST00000410072.1 |
DNAH7
|
dynein, axonemal, heavy chain 7 |
| chr3_-_196065248 | 8.56 |
ENST00000446879.1
ENST00000273695.3 |
TM4SF19
|
transmembrane 4 L six family member 19 |
| chr9_-_110251836 | 8.54 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
| chr16_+_2587965 | 8.54 |
ENST00000342085.4
ENST00000566659.1 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
| chr19_+_47759716 | 8.50 |
ENST00000221922.6
|
CCDC9
|
coiled-coil domain containing 9 |
| chr1_+_244998602 | 8.47 |
ENST00000411948.2
|
COX20
|
COX20 cytochrome C oxidase assembly factor |
| chr19_-_13213662 | 8.45 |
ENST00000264824.4
|
LYL1
|
lymphoblastic leukemia derived sequence 1 |
| chr19_+_1065922 | 8.38 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr19_+_544034 | 8.32 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
| chr6_-_27858570 | 8.20 |
ENST00000359303.2
|
HIST1H3J
|
histone cluster 1, H3j |
| chr19_+_859425 | 8.19 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
| chr3_-_127317047 | 8.17 |
ENST00000462228.1
ENST00000490643.1 |
TPRA1
|
transmembrane protein, adipocyte asscociated 1 |
| chr9_+_17134980 | 8.17 |
ENST00000380647.3
|
CNTLN
|
centlein, centrosomal protein |
| chr5_+_81575281 | 8.15 |
ENST00000380167.4
|
ATP6AP1L
|
ATPase, H+ transporting, lysosomal accessory protein 1-like |
| chr2_-_208489707 | 8.15 |
ENST00000448007.2
ENST00000432416.1 ENST00000411432.1 |
METTL21A
|
methyltransferase like 21A |
| chr12_-_91539918 | 8.14 |
ENST00000548218.1
|
DCN
|
decorin |
| chr17_-_42452063 | 8.08 |
ENST00000588098.1
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
| chr3_+_40547483 | 7.99 |
ENST00000420891.1
ENST00000314529.6 ENST00000418905.1 |
ZNF620
|
zinc finger protein 620 |
| chr1_-_27952741 | 7.96 |
ENST00000399173.1
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
| chr7_-_36764004 | 7.95 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
| chr1_-_11866034 | 7.94 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
| chr7_-_36764142 | 7.93 |
ENST00000258749.5
ENST00000535891.1 |
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
| chr1_+_16090914 | 7.92 |
ENST00000441801.2
|
FBLIM1
|
filamin binding LIM protein 1 |
| chr8_-_8318847 | 7.90 |
ENST00000521218.1
|
CTA-398F10.2
|
CTA-398F10.2 |
| chr5_+_54320078 | 7.90 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr5_-_131132658 | 7.88 |
ENST00000514667.1
ENST00000511848.1 ENST00000510461.1 |
CTC-432M15.3
FNIP1
|
Folliculin-interacting protein 1 folliculin interacting protein 1 |
| chr6_-_2842219 | 7.88 |
ENST00000380739.5
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
| chr2_-_217724767 | 7.87 |
ENST00000236979.2
|
TNP1
|
transition protein 1 (during histone to protamine replacement) |
| chr1_+_38022572 | 7.87 |
ENST00000541606.1
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr1_+_11866270 | 7.86 |
ENST00000376497.3
ENST00000376487.3 ENST00000376496.3 |
CLCN6
|
chloride channel, voltage-sensitive 6 |
| chr6_-_32160622 | 7.84 |
ENST00000487761.1
ENST00000375040.3 |
GPSM3
|
G-protein signaling modulator 3 |
| chr17_-_76836729 | 7.82 |
ENST00000587783.1
ENST00000542802.3 ENST00000586531.1 ENST00000589424.1 ENST00000590546.2 |
USP36
|
ubiquitin specific peptidase 36 |
| chr2_+_103089756 | 7.81 |
ENST00000295269.4
|
SLC9A4
|
solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 |
| chr16_-_4466622 | 7.71 |
ENST00000570645.1
ENST00000574025.1 ENST00000572898.1 ENST00000537233.2 ENST00000571059.1 ENST00000251166.4 |
CORO7
|
coronin 7 |
| chr17_-_15244894 | 7.70 |
ENST00000338696.2
ENST00000543896.1 ENST00000539245.1 ENST00000539316.1 ENST00000395930.1 |
TEKT3
|
tektin 3 |
| chr20_+_30639991 | 7.68 |
ENST00000534862.1
ENST00000538448.1 ENST00000375862.2 |
HCK
|
hemopoietic cell kinase |
| chr19_-_55866061 | 7.56 |
ENST00000588572.2
ENST00000593184.1 ENST00000589467.1 |
COX6B2
|
cytochrome c oxidase subunit VIb polypeptide 2 (testis) |
| chr11_+_28129795 | 7.54 |
ENST00000406787.3
ENST00000342303.5 ENST00000403099.1 ENST00000407364.3 |
METTL15
|
methyltransferase like 15 |
| chr1_+_209929377 | 7.53 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr1_-_169680745 | 7.52 |
ENST00000236147.4
|
SELL
|
selectin L |
| chr4_-_681114 | 7.50 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
| chr12_+_54892550 | 7.41 |
ENST00000545638.2
|
NCKAP1L
|
NCK-associated protein 1-like |
| chr4_+_113066552 | 7.39 |
ENST00000309733.5
|
C4orf32
|
chromosome 4 open reading frame 32 |
| chr19_-_21950362 | 7.38 |
ENST00000358296.6
|
ZNF100
|
zinc finger protein 100 |
| chr6_+_131894284 | 7.33 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
| chr12_+_69742121 | 7.28 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
| chrX_-_70329118 | 7.27 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
| chr17_+_80416050 | 7.26 |
ENST00000579198.1
ENST00000390006.4 ENST00000580296.1 |
NARF
|
nuclear prelamin A recognition factor |
| chr17_-_29641084 | 7.25 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
| chr10_-_21661870 | 7.25 |
ENST00000433460.1
|
RP11-275N1.1
|
RP11-275N1.1 |
| chr8_+_1993152 | 7.24 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
| chr7_-_99149715 | 7.23 |
ENST00000449309.1
|
FAM200A
|
family with sequence similarity 200, member A |
| chr16_+_2588012 | 7.22 |
ENST00000354836.5
ENST00000389224.3 |
PDPK1
|
3-phosphoinositide dependent protein kinase-1 |
| chr5_+_148786423 | 7.08 |
ENST00000505254.2
ENST00000602964.1 ENST00000519898.1 |
MIR143HG
|
MIR143 host gene (non-protein coding) |
| chr19_-_36822595 | 7.04 |
ENST00000585356.1
ENST00000438368.2 ENST00000590622.1 |
LINC00665
|
long intergenic non-protein coding RNA 665 |
| chrX_-_48433275 | 7.03 |
ENST00000376775.2
|
AC115618.1
|
Uncharacterized protein; cDNA FLJ26048 fis, clone PRS02384 |
| chr2_+_61108771 | 7.01 |
ENST00000394479.3
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
| chr8_-_61880248 | 6.95 |
ENST00000525556.1
|
AC022182.3
|
AC022182.3 |
| chr9_-_116102562 | 6.91 |
ENST00000374193.4
ENST00000465979.1 |
WDR31
|
WD repeat domain 31 |
| chr1_+_38022513 | 6.90 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
| chr19_-_14016877 | 6.90 |
ENST00000454313.1
ENST00000591586.1 ENST00000346736.2 |
C19orf57
|
chromosome 19 open reading frame 57 |
| chrX_+_37639264 | 6.87 |
ENST00000378588.4
|
CYBB
|
cytochrome b-245, beta polypeptide |
| chr4_-_156875003 | 6.84 |
ENST00000433477.3
|
CTSO
|
cathepsin O |
| chr19_-_39390350 | 6.82 |
ENST00000447739.1
ENST00000358931.5 ENST00000407552.1 |
SIRT2
|
sirtuin 2 |
| chr4_+_154622652 | 6.77 |
ENST00000260010.6
|
TLR2
|
toll-like receptor 2 |
| chr12_+_54891495 | 6.72 |
ENST00000293373.6
|
NCKAP1L
|
NCK-associated protein 1-like |
| chr17_+_27055798 | 6.72 |
ENST00000268766.6
|
NEK8
|
NIMA-related kinase 8 |
| chr19_-_54327542 | 6.71 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
| chr1_+_16062820 | 6.71 |
ENST00000294454.5
|
SLC25A34
|
solute carrier family 25, member 34 |
| chr18_+_74240756 | 6.58 |
ENST00000584910.1
ENST00000582452.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
| chr11_+_1940786 | 6.57 |
ENST00000278317.6
ENST00000381561.4 ENST00000381548.3 ENST00000360603.3 ENST00000381549.3 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr22_+_22786288 | 6.56 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr9_+_17135016 | 6.52 |
ENST00000425824.1
ENST00000262360.5 ENST00000380641.4 |
CNTLN
|
centlein, centrosomal protein |
| chr14_-_23288930 | 6.51 |
ENST00000554517.1
ENST00000285850.7 ENST00000397529.2 ENST00000555702.1 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr16_-_55866997 | 6.47 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
| chrX_+_49216659 | 6.46 |
ENST00000415752.1
|
GAGE12I
|
G antigen 12I |
| chr2_-_96811170 | 6.45 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
| chr3_+_10068095 | 6.43 |
ENST00000287647.3
ENST00000383807.1 ENST00000383806.1 ENST00000419585.1 |
FANCD2
|
Fanconi anemia, complementation group D2 |
| chr5_+_34929677 | 6.42 |
ENST00000342382.4
ENST00000382021.2 ENST00000303525.7 |
DNAJC21
|
DnaJ (Hsp40) homolog, subfamily C, member 21 |
| chrX_+_37639302 | 6.41 |
ENST00000545017.1
ENST00000536160.1 |
CYBB
|
cytochrome b-245, beta polypeptide |
| chr5_-_130970723 | 6.40 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
| chr7_+_72742178 | 6.40 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
| chr8_+_103563792 | 6.29 |
ENST00000285402.3
|
ODF1
|
outer dense fiber of sperm tails 1 |
| chr17_+_80416482 | 6.28 |
ENST00000309794.11
ENST00000345415.7 ENST00000457415.3 ENST00000584411.1 ENST00000412079.2 ENST00000577432.1 |
NARF
|
nuclear prelamin A recognition factor |
| chr1_+_209929494 | 6.26 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
| chr3_+_187871060 | 6.24 |
ENST00000448637.1
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
| chr5_+_80597419 | 6.23 |
ENST00000254037.2
ENST00000407610.3 ENST00000380199.5 |
ZCCHC9
|
zinc finger, CCHC domain containing 9 |
| chr19_-_50529193 | 6.21 |
ENST00000596445.1
ENST00000599538.1 |
VRK3
|
vaccinia related kinase 3 |
| chrY_+_15016725 | 6.20 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
| chr1_-_11865982 | 6.13 |
ENST00000418034.1
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
| chr3_+_32726774 | 6.10 |
ENST00000538368.1
|
CNOT10
|
CCR4-NOT transcription complex, subunit 10 |
| chr12_-_123849374 | 6.09 |
ENST00000602398.1
ENST00000602750.1 |
SBNO1
|
strawberry notch homolog 1 (Drosophila) |
| chr16_+_640201 | 6.07 |
ENST00000563109.1
|
RAB40C
|
RAB40C, member RAS oncogene family |
| chr7_-_142176790 | 6.06 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
| chr17_-_8021710 | 6.06 |
ENST00000380149.1
ENST00000448843.2 |
ALOXE3
|
arachidonate lipoxygenase 3 |
| chr7_+_150264365 | 6.06 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
| chr16_-_33647696 | 6.06 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr8_-_66474884 | 6.05 |
ENST00000520902.1
|
CTD-3025N20.2
|
CTD-3025N20.2 |
| chr7_-_71801980 | 6.05 |
ENST00000329008.5
|
CALN1
|
calneuron 1 |
| chr16_+_33020496 | 6.03 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr2_+_61108650 | 6.02 |
ENST00000295025.8
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
| chr11_-_33913708 | 5.99 |
ENST00000257818.2
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chr7_+_143013198 | 5.95 |
ENST00000343257.2
|
CLCN1
|
chloride channel, voltage-sensitive 1 |
| chr14_-_90798418 | 5.94 |
ENST00000354366.3
|
NRDE2
|
NRDE-2, necessary for RNA interference, domain containing |
| chr2_-_25475120 | 5.88 |
ENST00000380746.4
ENST00000402667.1 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
| chr7_+_5919458 | 5.85 |
ENST00000416608.1
|
OCM
|
oncomodulin |
| chr11_-_236326 | 5.82 |
ENST00000525237.1
ENST00000532956.1 ENST00000525319.1 ENST00000524564.1 ENST00000382743.4 |
SIRT3
|
sirtuin 3 |
| chr1_-_36948879 | 5.81 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
| chr2_+_219247021 | 5.81 |
ENST00000539932.1
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
| chr19_-_18366182 | 5.81 |
ENST00000355502.3
|
PDE4C
|
phosphodiesterase 4C, cAMP-specific |
| chr2_-_192016316 | 5.80 |
ENST00000358470.4
ENST00000432798.1 ENST00000450994.1 |
STAT4
|
signal transducer and activator of transcription 4 |
| chr6_+_31582961 | 5.79 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
| chr19_+_859654 | 5.74 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
| chr6_-_159421198 | 5.71 |
ENST00000252655.1
ENST00000297262.3 ENST00000367069.2 |
RSPH3
|
radial spoke 3 homolog (Chlamydomonas) |
| chrX_-_153191674 | 5.70 |
ENST00000350060.5
ENST00000370016.1 |
ARHGAP4
|
Rho GTPase activating protein 4 |
| chr10_-_76868931 | 5.66 |
ENST00000372700.3
ENST00000473072.2 ENST00000491677.2 ENST00000607131.1 ENST00000372702.3 |
DUSP13
|
dual specificity phosphatase 13 |
| chr14_-_106963409 | 5.66 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
| chr3_-_49459865 | 5.65 |
ENST00000427987.1
|
AMT
|
aminomethyltransferase |
| chr10_-_13523073 | 5.59 |
ENST00000440282.1
|
BEND7
|
BEN domain containing 7 |
| chr15_+_93749295 | 5.57 |
ENST00000599897.1
|
AC112693.2
|
AC112693.2 |
| chrX_+_56259316 | 5.55 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
| chr7_+_139478030 | 5.53 |
ENST00000425687.1
ENST00000263552.6 ENST00000438104.1 ENST00000336425.5 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
| chr1_-_67390474 | 5.53 |
ENST00000371023.3
ENST00000371022.3 ENST00000371026.3 ENST00000431318.1 |
WDR78
|
WD repeat domain 78 |
| chrX_+_123480194 | 5.52 |
ENST00000371139.4
|
SH2D1A
|
SH2 domain containing 1A |
| chr22_+_32149927 | 5.51 |
ENST00000437411.1
ENST00000535622.1 ENST00000536766.1 ENST00000400242.3 ENST00000266091.3 ENST00000400249.2 ENST00000400246.1 ENST00000382105.2 |
DEPDC5
|
DEP domain containing 5 |
| chr15_-_78423763 | 5.50 |
ENST00000557846.1
|
CIB2
|
calcium and integrin binding family member 2 |
| chr20_-_524362 | 5.49 |
ENST00000460062.2
ENST00000608066.1 |
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide |
| chr20_+_4702548 | 5.47 |
ENST00000305817.2
|
PRND
|
prion protein 2 (dublet) |
| chr19_-_4535233 | 5.47 |
ENST00000381848.3
ENST00000588887.1 ENST00000586133.1 |
PLIN5
|
perilipin 5 |
| chr17_-_40333099 | 5.44 |
ENST00000607371.1
|
KCNH4
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
| chr1_+_92417716 | 5.42 |
ENST00000402388.1
|
BRDT
|
bromodomain, testis-specific |
| chr2_+_68592305 | 5.41 |
ENST00000234313.7
|
PLEK
|
pleckstrin |
| chr11_+_71846764 | 5.32 |
ENST00000456237.1
ENST00000442948.2 ENST00000546166.1 |
FOLR3
|
folate receptor 3 (gamma) |
| chr11_-_133826852 | 5.30 |
ENST00000533871.2
ENST00000321016.8 |
IGSF9B
|
immunoglobulin superfamily, member 9B |
| chr17_-_29641104 | 5.28 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
| chr12_-_8025398 | 5.26 |
ENST00000535344.1
ENST00000543909.1 |
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14 |
| chr3_-_146213722 | 5.25 |
ENST00000336685.2
ENST00000489015.1 |
PLSCR2
|
phospholipid scramblase 2 |
| chr1_-_36947120 | 5.25 |
ENST00000361632.4
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
| chr5_-_176433350 | 5.23 |
ENST00000377227.4
ENST00000377219.2 |
UIMC1
|
ubiquitin interaction motif containing 1 |
| chr4_+_15704573 | 5.23 |
ENST00000265016.4
|
BST1
|
bone marrow stromal cell antigen 1 |
| chr12_-_8025442 | 5.22 |
ENST00000340749.5
ENST00000535295.1 ENST00000539234.1 |
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14 |
| chr2_-_97304105 | 5.21 |
ENST00000599854.1
ENST00000441706.2 |
KANSL3
|
KAT8 regulatory NSL complex subunit 3 |
| chr14_-_25103472 | 5.19 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
| chr19_+_55014013 | 5.19 |
ENST00000301202.2
|
LAIR2
|
leukocyte-associated immunoglobulin-like receptor 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of TBX1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.4 | 22.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 4.6 | 18.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 4.1 | 20.3 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 3.6 | 18.2 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 3.4 | 13.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 3.4 | 13.5 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 3.3 | 13.2 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 3.1 | 15.3 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 2.9 | 14.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 2.8 | 14.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 2.8 | 8.3 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.7 | 10.7 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
| 2.6 | 7.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 2.5 | 7.6 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 2.3 | 18.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 2.2 | 6.6 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 2.2 | 8.8 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.2 | 21.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 2.1 | 10.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 2.0 | 16.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 2.0 | 20.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 2.0 | 6.1 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
| 2.0 | 5.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.9 | 13.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 1.9 | 5.6 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 1.8 | 12.8 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 1.8 | 5.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.8 | 5.4 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 1.8 | 5.4 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 1.8 | 5.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 1.7 | 19.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 1.7 | 6.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 1.7 | 8.6 | GO:0050893 | sensory processing(GO:0050893) |
| 1.7 | 5.0 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 1.7 | 8.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.7 | 8.3 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 1.7 | 5.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 1.7 | 5.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 1.6 | 4.9 | GO:0043366 | beta selection(GO:0043366) |
| 1.6 | 4.9 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 1.6 | 4.9 | GO:1901189 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 1.6 | 3.2 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 1.6 | 4.9 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 1.6 | 1.6 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.6 | 4.7 | GO:0061010 | negative regulation of transcription by transcription factor localization(GO:0010621) gall bladder development(GO:0061010) |
| 1.6 | 4.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 1.5 | 1.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.5 | 4.5 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 1.5 | 4.5 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.5 | 19.4 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 1.5 | 8.9 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 1.5 | 7.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.5 | 4.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 1.5 | 8.8 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 1.5 | 1.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 1.5 | 7.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 1.5 | 43.6 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 1.5 | 10.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.4 | 11.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 1.4 | 4.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.4 | 2.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 1.3 | 4.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.3 | 5.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 1.3 | 3.9 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 1.3 | 16.5 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 1.3 | 3.8 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 1.2 | 5.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 1.2 | 1.2 | GO:0046602 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) centrosome separation(GO:0051299) |
| 1.2 | 6.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 1.2 | 6.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 1.2 | 3.6 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.2 | 7.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 1.2 | 1.2 | GO:0014806 | smooth muscle hyperplasia(GO:0014806) |
| 1.2 | 3.5 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 1.2 | 3.5 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 1.1 | 9.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 1.1 | 5.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.1 | 11.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 1.1 | 6.6 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 1.1 | 9.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 1.1 | 5.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 1.1 | 4.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 1.1 | 6.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 1.1 | 4.3 | GO:0045588 | allantoin metabolic process(GO:0000255) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
| 1.1 | 5.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 1.1 | 29.5 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 1.0 | 8.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 1.0 | 4.2 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 1.0 | 11.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.0 | 7.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.0 | 24.8 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 1.0 | 4.1 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 1.0 | 5.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.0 | 6.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.0 | 10.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.0 | 3.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.0 | 4.0 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 1.0 | 11.7 | GO:0031167 | rRNA methylation(GO:0031167) |
| 1.0 | 2.9 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 1.0 | 1.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 1.0 | 2.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 1.0 | 2.9 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.9 | 3.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.9 | 16.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.9 | 3.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.9 | 2.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.9 | 3.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.9 | 7.2 | GO:1902302 | regulation of potassium ion export(GO:1902302) regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.9 | 4.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.9 | 10.8 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.9 | 2.7 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.9 | 2.7 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.9 | 13.3 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
| 0.9 | 5.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.9 | 2.6 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.9 | 2.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.9 | 2.6 | GO:0008078 | mesoderm migration involved in gastrulation(GO:0007509) mesodermal cell migration(GO:0008078) |
| 0.9 | 1.7 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.9 | 7.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.8 | 2.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.8 | 3.4 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.8 | 14.9 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.8 | 1.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.8 | 4.1 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.8 | 0.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.8 | 2.4 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 0.8 | 3.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.8 | 2.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.8 | 16.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.8 | 2.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.8 | 1.5 | GO:0032762 | mast cell cytokine production(GO:0032762) |
| 0.8 | 2.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.8 | 4.6 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.8 | 3.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.8 | 4.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.8 | 5.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.8 | 2.3 | GO:0045082 | interleukin-4 biosynthetic process(GO:0042097) positive regulation of interleukin-10 biosynthetic process(GO:0045082) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.8 | 3.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.8 | 6.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.8 | 0.8 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.8 | 6.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.7 | 3.7 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.7 | 5.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.7 | 7.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.7 | 4.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.7 | 2.2 | GO:0033504 | floor plate development(GO:0033504) |
| 0.7 | 2.9 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.7 | 3.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.7 | 13.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.7 | 15.8 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.7 | 2.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.7 | 1.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.7 | 3.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.7 | 4.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.7 | 5.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.7 | 4.8 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.7 | 0.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.7 | 12.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.7 | 9.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.7 | 4.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.7 | 2.0 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.7 | 4.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.7 | 2.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.7 | 2.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.7 | 7.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.6 | 2.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.6 | 8.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.6 | 5.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.6 | 1.9 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.6 | 1.9 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.6 | 7.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.6 | 9.4 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.6 | 3.8 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 0.6 | 4.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.6 | 3.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.6 | 3.7 | GO:0015747 | urate transport(GO:0015747) |
| 0.6 | 4.9 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.6 | 14.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.6 | 1.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.6 | 2.4 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.6 | 13.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.6 | 2.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.6 | 3.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.6 | 2.4 | GO:1904327 | maintenance of unfolded protein(GO:0036506) protein localization to cytosolic proteasome complex(GO:1904327) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.6 | 10.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.6 | 1.2 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 0.6 | 8.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.6 | 2.3 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.6 | 9.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.6 | 4.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.6 | 4.0 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
| 0.6 | 2.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.6 | 38.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.6 | 2.8 | GO:0044336 | embryonic genitalia morphogenesis(GO:0030538) canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.6 | 1.7 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.6 | 5.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.6 | 1.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 7.2 | GO:0044144 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.5 | 1.6 | GO:1903463 | vacuolar phosphate transport(GO:0007037) regulation of mitotic cell cycle DNA replication(GO:1903463) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.5 | 2.7 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.5 | 1.6 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.5 | 6.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.5 | 2.2 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.5 | 1.1 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.5 | 0.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 | 0.5 | GO:0045399 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.5 | 3.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.5 | 1.1 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.5 | 2.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.5 | 1.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.5 | 1.6 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.5 | 7.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.5 | 4.2 | GO:0016236 | macroautophagy(GO:0016236) |
| 0.5 | 2.1 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.5 | 1.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.5 | 3.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.5 | 2.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.5 | 10.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.5 | 1.5 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 0.5 | 3.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.5 | 3.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.5 | 1.5 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.5 | 3.5 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.5 | 2.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.5 | 1.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.5 | 0.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.5 | 4.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.5 | 1.5 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.5 | 1.0 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
| 0.5 | 2.4 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.5 | 5.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.5 | 1.4 | GO:0045925 | female courtship behavior(GO:0008050) positive regulation of female receptivity(GO:0045925) |
| 0.5 | 1.9 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.5 | 2.8 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.5 | 6.6 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.5 | 3.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.5 | 2.3 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.5 | 0.9 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 0.5 | 2.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.5 | 20.0 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.5 | 2.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.5 | 1.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.4 | 6.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 | 2.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 | 2.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.4 | 1.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 1.3 | GO:0046219 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.4 | 1.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.4 | 10.4 | GO:0033198 | response to ATP(GO:0033198) |
| 0.4 | 3.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.4 | 3.3 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.4 | 2.0 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.4 | 1.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.4 | 1.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) protein localization to ciliary transition zone(GO:1904491) |
| 0.4 | 1.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.4 | 1.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.4 | 5.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.4 | 0.8 | GO:0043132 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) NAD transport(GO:0043132) |
| 0.4 | 7.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 | 1.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.4 | 1.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.4 | 1.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.4 | 7.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.4 | 1.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.4 | 4.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 2.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.4 | 8.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.4 | 4.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 | 2.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 | 3.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.4 | 2.3 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.4 | 9.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 | 3.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.4 | 4.8 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.4 | 0.7 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.4 | 2.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.4 | 1.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.4 | 5.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.4 | 1.1 | GO:0035054 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 | 2.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.4 | 1.1 | GO:0035283 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.4 | 4.0 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.4 | 7.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.4 | 2.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.4 | 1.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.4 | 2.8 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.4 | 1.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.4 | 3.2 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.4 | 3.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.3 | 2.4 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.3 | 1.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 | 5.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 | 6.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.3 | 28.7 | GO:0050776 | regulation of immune response(GO:0050776) |
| 0.3 | 1.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.3 | 2.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.3 | 5.7 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.3 | 1.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.3 | 8.0 | GO:0003341 | cilium movement(GO:0003341) |
| 0.3 | 3.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.3 | 1.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 8.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.3 | 4.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.3 | 1.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.3 | 12.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.3 | 1.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.3 | 2.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.3 | 7.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.3 | 2.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.3 | 20.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.3 | 1.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.3 | 1.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.3 | 0.6 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.3 | 10.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 | 5.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.3 | 0.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.3 | 3.9 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.3 | 9.6 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.3 | 3.3 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.3 | 1.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.3 | 3.6 | GO:0015871 | choline transport(GO:0015871) |
| 0.3 | 3.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.3 | 3.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.3 | 2.0 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 | 1.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.3 | 1.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.3 | 0.9 | GO:0048850 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
| 0.3 | 1.4 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.3 | 4.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.3 | 2.0 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) membrane protein proteolysis(GO:0033619) |
| 0.3 | 0.8 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.3 | 1.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.3 | 2.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.3 | 8.3 | GO:0019835 | cytolysis(GO:0019835) |
| 0.3 | 4.7 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.3 | 0.8 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 | 5.0 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.3 | 3.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 | 5.2 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.3 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.3 | 1.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 5.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 | 2.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.3 | 1.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.3 | 0.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.3 | 1.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 | 1.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.3 | 2.7 | GO:0046514 | ceramide catabolic process(GO:0046514) |
| 0.3 | 1.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.3 | 3.7 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.3 | 8.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 | 5.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.3 | 0.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.3 | 1.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.3 | 8.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.3 | 9.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.3 | 1.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.3 | 2.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.3 | 10.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.3 | 2.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.3 | 2.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.3 | 7.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.2 | 2.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 2.2 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.2 | 1.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 | 8.5 | GO:0030317 | sperm motility(GO:0030317) |
| 0.2 | 4.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.2 | 1.2 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 | 4.7 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.2 | 1.6 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.2 | 5.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 | 2.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 2.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 1.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 3.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 1.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 0.9 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.2 | 1.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 11.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 3.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.2 | 1.5 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 | 1.0 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.2 | 1.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 | 1.7 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 | 1.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 3.5 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.2 | 2.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.2 | 5.9 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
| 0.2 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 2.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.2 | 5.5 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
| 0.2 | 6.1 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.2 | 1.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.2 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 0.8 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.2 | 1.8 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 14.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.2 | 1.4 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.2 | 2.8 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.2 | 2.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.2 | 2.7 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.2 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 0.2 | 5.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.2 | 11.4 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.2 | 1.3 | GO:0060326 | cell chemotaxis(GO:0060326) |
| 0.2 | 0.7 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 | 3.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 | 1.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 13.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.2 | 1.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 3.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 | 0.7 | GO:1901159 | xylulose metabolic process(GO:0005997) glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 | 1.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 3.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 3.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.2 | 21.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.2 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 | 3.4 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
| 0.2 | 1.5 | GO:0051781 | positive regulation of cell division(GO:0051781) |
| 0.2 | 3.4 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.2 | 1.3 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 | 5.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 7.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.2 | 0.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 1.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 2.9 | GO:0007618 | mating(GO:0007618) |
| 0.2 | 2.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.2 | 4.8 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
| 0.2 | 14.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.2 | 16.8 | GO:0042742 | defense response to bacterium(GO:0042742) |
| 0.2 | 6.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 | 0.3 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
| 0.2 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.2 | 5.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.2 | 0.9 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.2 | 0.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 | 1.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.2 | 3.1 | GO:0048536 | spleen development(GO:0048536) |
| 0.2 | 0.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 3.0 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 1.2 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 1.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 | 10.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 2.9 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 2.8 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.1 | 3.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 3.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 1.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.1 | 5.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.1 | 0.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 0.7 | GO:0031329 | regulation of cellular catabolic process(GO:0031329) |
| 0.1 | 1.5 | GO:0070482 | response to oxygen levels(GO:0070482) |
| 0.1 | 2.2 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.4 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 | 1.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 1.0 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 0.8 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.1 | 0.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 | 2.9 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 | 1.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 0.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 | 1.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 3.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.7 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.1 | 0.7 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.1 | 2.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.1 | 1.4 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.1 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 | 1.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.1 | 3.5 | GO:0006959 | humoral immune response(GO:0006959) |
| 0.1 | 1.1 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 3.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 1.1 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 1.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 1.0 | GO:0060348 | bone development(GO:0060348) |
| 0.1 | 0.9 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 0.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.1 | 2.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.5 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 | 4.9 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.1 | 2.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 1.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 1.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.3 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.1 | 1.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 0.3 | GO:0021549 | cerebellum development(GO:0021549) metencephalon development(GO:0022037) |
| 0.1 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 1.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.1 | 3.3 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
| 0.1 | 1.3 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.1 | 0.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 2.8 | GO:0021510 | spinal cord development(GO:0021510) |
| 0.1 | 1.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.1 | 1.5 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.1 | 0.5 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 1.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.1 | 14.2 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.1 | 0.7 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.1 | 2.7 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
| 0.1 | 1.6 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.1 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.1 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 1.2 | GO:0051647 | nucleus localization(GO:0051647) |
| 0.1 | 4.6 | GO:0007259 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
| 0.1 | 0.3 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 2.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 | 4.6 | GO:0007286 | spermatid development(GO:0007286) |
| 0.1 | 0.8 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 1.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 3.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.3 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.1 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.1 | 2.4 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.1 | 1.0 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.2 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 | 1.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 0.1 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.2 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 2.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 1.5 | GO:0043523 | regulation of neuron apoptotic process(GO:0043523) |
| 0.1 | 0.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 2.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 1.8 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.6 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.1 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.5 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.1 | 0.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.0 | 1.0 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.0 | 1.8 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
| 0.0 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 1.9 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.0 | 0.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 3.0 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 | 1.5 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 2.3 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 | 2.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 1.1 | GO:0008542 | visual learning(GO:0008542) |
| 0.0 | 0.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.0 | 1.2 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 2.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
| 0.0 | 1.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.5 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.0 | 2.6 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.0 | 1.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 | 0.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.0 | 0.4 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 | 0.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 | 1.4 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
| 0.0 | 0.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 | 0.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.0 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 | 0.3 | GO:0060324 | face development(GO:0060324) |
| 0.0 | 0.0 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.0 | 0.8 | GO:0001764 | neuron migration(GO:0001764) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.1 | 40.5 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 7.1 | 21.3 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 3.4 | 13.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 2.6 | 15.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 2.3 | 6.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 2.1 | 21.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.8 | 12.8 | GO:0001520 | outer dense fiber(GO:0001520) |
| 1.8 | 14.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.8 | 5.3 | GO:0036030 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 1.4 | 4.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 1.4 | 4.2 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 1.4 | 8.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 1.3 | 3.9 | GO:0044609 | DBIRD complex(GO:0044609) |
| 1.3 | 11.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 1.2 | 8.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 1.1 | 8.0 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.1 | 10.1 | GO:0005638 | lamin filament(GO:0005638) |
| 1.1 | 13.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 1.1 | 7.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 1.1 | 5.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.0 | 14.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 1.0 | 3.0 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 1.0 | 4.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 1.0 | 9.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 1.0 | 4.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.9 | 2.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.9 | 5.5 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.9 | 15.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.9 | 12.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.8 | 4.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.8 | 4.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.8 | 39.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.8 | 5.7 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.8 | 3.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.8 | 4.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.7 | 3.6 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.7 | 10.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.7 | 3.6 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.7 | 3.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.7 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.7 | 3.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.7 | 5.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.7 | 2.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.6 | 5.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.6 | 2.5 | GO:0070695 | FHF complex(GO:0070695) |
| 0.6 | 15.3 | GO:0032982 | myosin filament(GO:0032982) |
| 0.6 | 4.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.6 | 2.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.6 | 10.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.6 | 8.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.6 | 5.2 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.6 | 7.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.6 | 0.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.6 | 18.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.5 | 2.7 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.5 | 2.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.5 | 2.7 | GO:0032021 | NELF complex(GO:0032021) |
| 0.5 | 1.6 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.5 | 3.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.5 | 5.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.5 | 1.5 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.5 | 2.4 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.5 | 1.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.5 | 4.7 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.4 | 2.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.4 | 5.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.4 | 14.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.4 | 1.7 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.4 | 3.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.4 | 4.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.4 | 3.7 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.4 | 9.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.4 | 1.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 1.2 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.4 | 10.7 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.4 | 1.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.4 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.4 | 10.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.4 | 17.0 | GO:0000791 | euchromatin(GO:0000791) |
| 0.4 | 3.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.4 | 8.5 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.4 | 3.2 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.3 | 8.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.3 | 2.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.3 | 3.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.3 | 1.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.3 | 3.3 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 11.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 5.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.3 | 5.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 5.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.3 | 7.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.3 | 2.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.3 | 2.8 | GO:0032039 | integrator complex(GO:0032039) |
| 0.3 | 23.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.3 | 48.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.3 | 0.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.3 | 21.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.3 | 5.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.3 | 1.6 | GO:0051286 | cell tip(GO:0051286) |
| 0.3 | 20.7 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.3 | 30.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 3.0 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 1.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.3 | 1.5 | GO:0097227 | septin complex(GO:0031105) sperm annulus(GO:0097227) |
| 0.2 | 6.6 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.2 | 11.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 2.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 25.0 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.2 | 5.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 1.4 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.2 | 3.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 3.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 25.2 | GO:0043204 | perikaryon(GO:0043204) |
| 0.2 | 21.0 | GO:0031514 | motile cilium(GO:0031514) |
| 0.2 | 2.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.2 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.2 | 2.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.2 | 0.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.2 | 4.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 10.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.2 | 1.8 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.2 | 1.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 2.3 | GO:0005902 | microvillus(GO:0005902) |
| 0.2 | 8.2 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.2 | 8.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 3.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 3.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 2.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 3.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 7.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 19.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 4.0 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 3.2 | GO:0031674 | Z disc(GO:0030018) I band(GO:0031674) |
| 0.1 | 1.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
| 0.1 | 2.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 3.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 16.3 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 26.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 2.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 4.7 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 11.9 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 1.8 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 2.2 | GO:0097546 | ciliary base(GO:0097546) |
| 0.1 | 3.4 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 1.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 2.3 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 3.6 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 2.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 3.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 1.6 | GO:0005861 | troponin complex(GO:0005861) |
| 0.1 | 4.5 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 7.3 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 3.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 10.7 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 1.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 2.9 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.1 | 3.4 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 2.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 1.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 2.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 10.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.0 | 3.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.0 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 1.3 | GO:0034702 | ion channel complex(GO:0034702) |
| 0.0 | 3.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 38.4 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 34.7 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 0.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.0 | 2.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 1.0 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 3.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.8 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.2 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 1.0 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.2 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.2 | 24.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 5.3 | 15.9 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 4.6 | 18.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 4.0 | 40.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 3.6 | 10.9 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 3.6 | 14.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 3.5 | 14.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 3.1 | 9.4 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 2.9 | 8.8 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 2.8 | 14.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 2.8 | 8.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 2.7 | 10.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 2.5 | 10.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 2.4 | 12.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 2.4 | 7.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
| 2.3 | 2.3 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 2.2 | 31.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 2.2 | 13.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 2.2 | 6.6 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 2.2 | 6.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 2.0 | 6.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 2.0 | 8.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 2.0 | 8.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 1.9 | 9.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 1.8 | 5.5 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 1.8 | 9.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 1.8 | 5.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.7 | 8.5 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 1.7 | 8.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 1.7 | 5.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 1.6 | 22.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 1.5 | 6.1 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 1.5 | 4.5 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.5 | 5.9 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.5 | 5.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 1.4 | 4.3 | GO:0004040 | amidase activity(GO:0004040) |
| 1.4 | 4.1 | GO:0048030 | disaccharide binding(GO:0048030) |
| 1.4 | 5.5 | GO:0035473 | lipase binding(GO:0035473) |
| 1.3 | 4.0 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 1.3 | 4.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 1.3 | 5.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 1.3 | 23.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 1.3 | 22.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 1.2 | 3.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 1.2 | 7.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.2 | 4.8 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 1.2 | 3.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 1.2 | 3.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 1.1 | 4.6 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
| 1.1 | 11.5 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 1.1 | 3.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.1 | 4.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 1.1 | 57.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 1.1 | 3.3 | GO:0004802 | transketolase activity(GO:0004802) |
| 1.1 | 7.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.1 | 9.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 1.1 | 6.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 1.0 | 6.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.0 | 4.1 | GO:0038047 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 1.0 | 5.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 1.0 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 1.0 | 5.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 1.0 | 2.9 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 1.0 | 3.9 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 1.0 | 7.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.9 | 3.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.9 | 2.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.9 | 3.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.9 | 4.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.9 | 3.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.9 | 9.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.9 | 2.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.9 | 9.2 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 0.9 | 3.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.9 | 3.7 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.9 | 3.6 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
| 0.9 | 3.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.9 | 2.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.9 | 13.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.9 | 2.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.9 | 4.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.9 | 4.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.8 | 4.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.8 | 18.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.8 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.8 | 4.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.8 | 4.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.8 | 2.4 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.8 | 2.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.8 | 4.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.8 | 2.4 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.8 | 3.9 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.8 | 15.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.8 | 7.6 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.7 | 6.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.7 | 6.0 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.7 | 3.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.7 | 5.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.7 | 2.2 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.7 | 7.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.7 | 4.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.7 | 15.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.7 | 3.3 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.7 | 2.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.7 | 10.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.6 | 1.9 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.6 | 6.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.6 | 10.8 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.6 | 9.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.6 | 10.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.6 | 1.9 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.6 | 3.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.6 | 7.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.6 | 2.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.6 | 6.0 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.6 | 1.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.6 | 3.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.6 | 9.2 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.6 | 2.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.6 | 3.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.6 | 4.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.6 | 7.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.6 | 5.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.6 | 2.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.6 | 1.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.5 | 2.7 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.5 | 2.7 | GO:0015087 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.5 | 6.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.5 | 2.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.5 | 2.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.5 | 4.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.5 | 5.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.5 | 3.6 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.5 | 2.0 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.5 | 3.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.5 | 1.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.5 | 5.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.5 | 3.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.5 | 8.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.5 | 3.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.5 | 2.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.5 | 3.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.5 | 5.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.5 | 2.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.5 | 1.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.5 | 2.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.5 | 12.7 | GO:0005521 | lamin binding(GO:0005521) |
| 0.5 | 1.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.5 | 5.0 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.4 | 3.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.4 | 25.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.4 | 5.3 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.4 | 2.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.4 | 7.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.4 | 5.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.4 | 1.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.4 | 1.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.4 | 7.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.4 | 22.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.4 | 3.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.4 | 2.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.4 | 3.7 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.4 | 9.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.4 | 5.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.4 | 4.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.4 | 2.4 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.4 | 1.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.4 | 1.2 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.4 | 0.8 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.4 | 2.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.4 | 1.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.4 | 7.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.4 | 6.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
| 0.4 | 3.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.4 | 6.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.4 | 17.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.4 | 2.6 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 0.4 | 6.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 1.1 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.4 | 1.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.4 | 2.8 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.4 | 4.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.4 | 5.7 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.4 | 3.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.4 | 1.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.4 | 1.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.4 | 2.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.3 | 2.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.3 | 1.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.3 | 1.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.3 | 6.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 2.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.3 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.3 | 12.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.3 | 1.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.3 | 5.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.3 | 11.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.3 | 1.6 | GO:0097108 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
| 0.3 | 1.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.3 | 13.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.3 | 0.9 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.3 | 2.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.3 | 7.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.3 | 6.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.3 | 1.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.3 | 16.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.3 | 1.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.3 | 4.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 7.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 5.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.3 | 4.8 | GO:0031005 | filamin binding(GO:0031005) |
| 0.3 | 2.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.3 | 2.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.3 | 0.8 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.3 | 1.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.3 | 0.8 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.3 | 1.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.3 | 2.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.3 | 1.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 1.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.3 | 6.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.3 | 2.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.3 | 7.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.3 | 0.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.3 | 1.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.3 | 2.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 3.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 9.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.3 | 68.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.3 | 1.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.3 | 3.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.3 | 9.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.3 | 1.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.3 | 0.8 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.3 | 4.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 3.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.2 | 12.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.2 | 1.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.2 | 2.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 1.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 9.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.2 | 2.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.2 | 13.8 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.2 | 1.6 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 0.7 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.2 | 2.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.2 | 0.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.2 | 5.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 2.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.2 | 3.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 4.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 4.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.2 | 1.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 2.6 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
| 0.2 | 2.8 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.2 | 1.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.2 | 4.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.2 | 4.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 1.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 1.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 1.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 7.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 4.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 5.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.2 | 6.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 3.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 4.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 1.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.2 | 13.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.2 | 8.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.2 | 3.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.2 | 2.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.2 | 20.4 | GO:0003823 | antigen binding(GO:0003823) |
| 0.2 | 8.5 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.2 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 0.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.2 | 0.5 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.2 | 1.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 1.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 1.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.2 | 3.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 2.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 2.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 1.3 | GO:0004954 | prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.2 | 0.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
| 0.2 | 0.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 1.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 2.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 1.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 2.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 3.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 1.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 6.6 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.1 | 9.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 4.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 1.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 2.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.1 | 9.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 5.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 5.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 3.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 1.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.1 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 1.2 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 2.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 2.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 6.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.5 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.1 | 1.3 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 1.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 10.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 3.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 1.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 1.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 1.7 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 6.9 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 34.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 3.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 4.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 3.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.1 | 2.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 4.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 1.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.1 | 0.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 2.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.3 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 1.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 3.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.9 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.1 | 1.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 1.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.1 | 4.4 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
| 0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 1.2 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.7 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
| 0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 1.3 | GO:0042165 | neurotransmitter binding(GO:0042165) acetylcholine binding(GO:0042166) |
| 0.1 | 83.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.5 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 0.1 | 1.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.7 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 1.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.1 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 1.7 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 1.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.1 | 11.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.1 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 1.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 2.6 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 2.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.0 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.0 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.0 | 1.4 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.0 | 1.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 0.3 | GO:0003774 | motor activity(GO:0003774) |
| 0.0 | 2.1 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 1.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 5.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.0 | 1.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.0 | 0.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 8.7 | GO:0004888 | transmembrane signaling receptor activity(GO:0004888) |
| 0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 0.2 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 59.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 1.4 | 57.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.8 | 15.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.7 | 16.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.5 | 6.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.5 | 28.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.5 | 1.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.5 | 2.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.5 | 44.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.5 | 11.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.5 | 15.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.4 | 11.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.4 | 22.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.4 | 13.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.4 | 2.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.4 | 4.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.3 | 27.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.3 | 12.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 10.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.3 | 6.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.3 | 4.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.3 | 10.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 4.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 5.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 5.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.3 | 9.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.3 | 11.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.2 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 4.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 11.7 | PID ATM PATHWAY | ATM pathway |
| 0.2 | 6.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 5.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 4.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 2.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 3.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 42.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.2 | 21.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.2 | 6.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.2 | 26.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 6.7 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 3.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 5.0 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 4.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 7.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 3.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 2.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 1.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 2.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.1 | 2.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 1.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.1 | 3.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 2.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 1.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 1.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 1.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 29.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.1 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 2.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 1.1 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 3.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 3.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 3.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 2.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 1.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 2.5 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 4.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.0 | 1.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 1.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 0.6 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 1.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 24.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.9 | 19.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.9 | 56.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.9 | 6.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.9 | 17.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.8 | 4.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.8 | 61.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.8 | 8.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.8 | 9.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.7 | 11.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.7 | 13.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.7 | 7.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.6 | 14.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.6 | 9.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.6 | 2.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.6 | 6.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.5 | 10.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.5 | 8.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.5 | 10.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.5 | 29.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.5 | 11.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.5 | 9.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.5 | 14.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.5 | 4.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.4 | 31.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.4 | 8.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.4 | 7.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.4 | 5.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.4 | 4.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.4 | 19.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.4 | 4.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.4 | 137.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.4 | 16.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.4 | 6.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.3 | 3.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.3 | 9.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.3 | 2.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.3 | 15.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.3 | 9.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.3 | 3.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.3 | 5.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 6.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.2 | 24.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 9.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.2 | 4.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
| 0.2 | 4.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.2 | 4.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 13.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.2 | 2.4 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
| 0.2 | 4.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 5.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.2 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 4.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.2 | 10.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.2 | 5.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.2 | 2.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.2 | 9.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 8.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 8.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 1.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 3.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 1.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 2.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.1 | 2.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 5.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 2.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 3.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 2.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 16.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.1 | 1.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 1.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.1 | 9.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 5.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 4.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 3.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 2.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 2.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 0.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 2.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 1.9 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
| 0.1 | 2.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 3.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 2.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 4.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 2.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 1.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 1.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 1.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 1.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 6.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 1.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 2.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 2.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 2.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 0.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |